Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17896517 | 0.94 | TDP1 (0.55) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL16627110 | 0.92 | TDP1 (0.53) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL394866 | 0.90 | TDP1 (0.52) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL513612 | 0.90 | TDP1 (0.61) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL20127259 | 0.89 | CA1 (0.58) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL513611 | 0.88 | TDP1 (0.53) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL16785739 | 0.87 | RAB9A (0.49) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL206554 | 0.86 | TDP1 (0.61) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL235800 | 0.86 | CA2 (0.73) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL15592615 | 0.86 | CA2 (0.56) | TDP1RAB9AALDH1A1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240019738-A1 | DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | JAPAN DISPLAY INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-10011772-B2 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9976086-B2 | Liquid crystal aligning agent containing polyimide precursor having thermally-leaving group and/or polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9864104-B2 | Blend prepared by mixing a prepolymer and a vinyl monomer and a polymer sheet obtained therefrom | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2018-01-09 | — | — | US | disclosed |
| US-9732253-B2 | Polyimide precursor, polyimide, and coating solution for under layer film for image formation | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-08-15 | — | — | US | disclosed |
| US-20160264867-A1 | LIQUID CRYSTAL ALIGNING AGENT CONTAINING POLYIMIDE PRECURSOR HAVING THERMALLY-LEAVING GROUP AND/OR POLYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| EP-2640728-B1 | NOVEL MONENSIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF PROTOZOAL INFECTIONS | MERIAL INC (US) | 2016-09-07 | — | — | EP | disclosed |
| US-20160244673-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-9340691-B2 | Hot melt ink composition comprising a copolyester and process for preparing a copolyester | OCE-TECHNOLOGIES B.V. (NL) | 2016-05-17 | — | — | US | disclosed |
| US-9303176-B2 | Hot melt ink composition, method for preparing a hot melt ink composition and use of a hot melt ink composition | OCE-TECHNOLOGIES B.V. (NL) | 2016-04-05 | — | — | US | disclosed |
| US-20120128722-A1 | Novel Monensin Derivatives for the Treatment and Prevention of Protozoal Infections | MERIAL, INC. | 2012-05-24 | — | — | US | disclosed |
| US-20120101236-A1 | POLYIMIDE PRECURSOR COMPOSITION CONTAINING POLYAMIC ACID ALKYL ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20100172623-A1 | COMPOUND CONTAINING CROSSLINKABLE MOIETIES, PREPOLYMER, BLEND AND POLYMER SHEET OBTAINED THEREFROM, AND WAVEGUIDE FOR OPTICAL INTERCONNECTION | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2010-07-08 | — | — | US | disclosed |
| US-20100069569-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND COATING SOLUTION FOR UNDER LAYER FILM FOR IMAGE FORMATION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100069569-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND COATING SOLUTION FOR UNDER LAYER FILM FOR IMAGE FORMATION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20090184347-A1 | COATING LIQUID FOR GATE INSULATING FILM, GATE INSULATING FILM AND ORGANIC TRANSISTOR | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090184347-A1 | COATING LIQUID FOR GATE INSULATING FILM, GATE INSULATING FILM AND ORGANIC TRANSISTOR | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-2028683-A1 | COATING LIQUID FOR GATE INSULATING FILM, GATE INSULATING FILM AND ORGANIC TRANSISTOR | Nissan Chemical Industries, Ltd. (JP) | 2009-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172623-A1 | COMPOUND CONTAINING CROSSLINKABLE MOIETIES, PREPOLYMER, BLEND AND POLYMER SHEET OBTAINED THEREFROM, AND WAVEGUIDE FOR OPTICAL INTERCONNECTION | CBS, CTH, WASF2 | TDP1 4462/4885RAB9A 2877/4885ALDH1A1 2667/4885 |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | TDP1 242/4885RAB9A 1123/4885ALDH1A1 4072/4885 |
| US-20120128722-A1 | Novel Monensin Derivatives for the Treatment and Prevention of Protozoal Infections | MON2, SLC26A4, ABCB11 | TDP1 4630/4885RAB9A 979/4885ALDH1A1 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.